Agilis Robotics establishes Boston subsidiary
Agilis Robotics established a North American subsidiary in Boston to support U.S. regulatory and commercial work.
Evidence notes
- The Boston company was formally established on 27 December 2023.
- Agilis used the expansion to begin FDA 510(k) work for its endoscopic surgical robot.
- The company described Boston as a base for overseas medical-institution relationships and market feedback.
Company context
Agilis Robotics develops miniature flexible robotic instruments for endoluminal surgery. The platform is designed to navigate natural anatomical pathways and give surgeons dexterous control in procedures where conventional rigid instruments have limited reach.